Valuation Mega Lifesciences Thailand S.E.

Stocks

End-of-day quote Thailand S.E. 29/10/2026			5-day change	1st Jan Change
32.75 ^THB	-3.68%		-5.07%	-2.24%

25/08	Mega Lifesciences Public Company Limited, Q2 2026 Earnings Call, Aug 14, 2026
13/08	Mega Lifesciences Public Company Limited Announces Declaration of Interim Dividend for Period from 01 January 2026 to 30 June 2026, Payable on 11 September 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	44,029	40,760	35,093	28,990	29,208	28,554	-	-
Change	-	-7.43%	-13.9%	-17.39%	0.75%	-2.24%	-	-
Enterprise Value (EV) ¹	41,666	38,309	32,456	25,464	25,051	23,937	23,834	23,500
Change	-	-8.06%	-15.28%	-21.54%	-1.62%	-4.45%	-0.43%	-1.4%
P/E	22.6x	18.2x	17.6x	14.4x	15.3x	12.5x	11.5x	10.8x
PBR	5.5x	4.64x	3.77x	2.94x	2.86x	2.6x	2.58x	2.49x
PEG	-	1.2x	-1.6x	16.49x	-2.95x	0.7x	1.24x	1.62x
Capitalization / Revenue	3.08x	2.6x	2.24x	1.89x	2.06x	1.99x	1.84x	1.75x
EV / Revenue	2.91x	2.44x	2.07x	1.66x	1.77x	1.67x	1.54x	1.44x
EV / EBITDA	17.2x	13x	10.2x	6.78x	8.73x	7.56x	6.74x	6.24x
EV / EBIT	18.1x	14.3x	11.2x	7.56x	9.69x	8.54x	7.49x	6.94x
EV / FCF	16.2x	22.6x	19.6x	11.8x	11.9x	10.5x	11.6x	10.8x
FCF Yield	6.18%	4.42%	5.09%	8.46%	8.41%	9.54%	8.59%	9.28%
Dividend per Share ²	1.06	1.61	1.65	1.6	1.6	1.782	1.909	2.039
Rate of return	2.1%	3.44%	4.1%	4.81%	4.78%	5.44%	5.83%	6.22%
EPS ²	2.23	2.57	2.29	2.31	2.19	2.61	2.851	3.041
Distribution rate	47.5%	62.6%	72.1%	69.3%	73.1%	68.3%	66.9%	67%
Net sales ¹	14,301	15,686	15,681	15,344	14,147	14,330	15,499	16,271
EBITDA ¹	2,426	2,953	3,190	3,756	2,868	3,167	3,537	3,768
EBIT ¹	2,305	2,681	2,904	3,370	2,585	2,803	3,181	3,384
Net income ¹	1,947	2,242	1,993	2,012	1,912	2,243	2,486	2,652
Net Debt ¹	-2,363	-2,451	-2,636	-3,525	-4,156	-4,617	-4,720	-5,053
Reference price ²	50.50	46.75	40.25	33.25	33.50	32.75	32.75	32.75
Nbr of stocks (in thousands)	871,870	871,870	871,870	871,870	871,870	871,870	-	-
Announcement Date	23/2/22	25/2/23	22/2/24	24/2/25	24/2/26	-	-	-

¹THB in Million²THB

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,148B
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	652B
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	505B
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	384B
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	348B
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	294B
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	264B
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	244B
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	197B
Average	29.56x	7.11x	18.84x	2.11%	448.57B
Weighted average by Cap.	35.29x	8.40x	20.64x	1.79%